Ascent Group LLC reduced its stake in shares of Equitable Holdings, Inc. (NYSE:EQH – Free Report) by 3.9% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 6,382 shares of the company’s stock after selling 258 shares during the quarter. Ascent Group LLC’s holdings in Equitable were worth $261,000 as of its most recent SEC filing.
Other large investors also recently modified their holdings of the company. New Covenant Trust Company N.A. acquired a new stake in shares of Equitable during the 1st quarter worth $28,000. LRI Investments LLC acquired a new stake in Equitable in the first quarter valued at about $45,000. Rise Advisors LLC boosted its stake in Equitable by 1,421.4% in the first quarter. Rise Advisors LLC now owns 1,704 shares of the company’s stock valued at $65,000 after buying an additional 1,592 shares in the last quarter. GAMMA Investing LLC boosted its stake in Equitable by 26.4% in the first quarter. GAMMA Investing LLC now owns 1,939 shares of the company’s stock valued at $74,000 after buying an additional 405 shares in the last quarter. Finally, Quarry LP acquired a new stake in Equitable in the fourth quarter valued at about $76,000. 92.70% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Several research firms recently weighed in on EQH. Truist Financial raised their price objective on Equitable from $44.00 to $52.00 and gave the company a “buy” rating in a research note on Thursday, August 1st. Citigroup raised their price objective on Equitable from $41.00 to $53.00 and gave the company a “buy” rating in a research note on Tuesday, July 23rd. JPMorgan Chase & Co. raised their price objective on Equitable from $36.00 to $45.00 and gave the company a “neutral” rating in a research note on Tuesday, July 2nd. UBS Group lowered Equitable from a “buy” rating to a “neutral” rating and raised their price objective for the company from $40.00 to $43.00 in a research note on Tuesday, June 18th. Finally, Barclays initiated coverage on Equitable in a research note on Wednesday, September 4th. They set an “overweight” rating and a $59.00 price target on the stock. Four research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $46.64.
Insiders Place Their Bets
In other Equitable news, COO Jeffrey J. Hurd sold 9,969 shares of Equitable stock in a transaction that occurred on Monday, July 15th. The stock was sold at an average price of $43.09, for a total value of $429,564.21. Following the completion of the sale, the chief operating officer now directly owns 111,552 shares in the company, valued at $4,806,775.68. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In other news, COO Jeffrey J. Hurd sold 9,969 shares of the business’s stock in a transaction that occurred on Monday, July 15th. The stock was sold at an average price of $43.09, for a total transaction of $429,564.21. Following the completion of the sale, the chief operating officer now owns 111,552 shares in the company, valued at $4,806,775.68. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO Mark Pearson sold 30,000 shares of the business’s stock in a transaction that occurred on Monday, September 16th. The shares were sold at an average price of $40.78, for a total value of $1,223,400.00. Following the sale, the chief executive officer now owns 668,555 shares of the company’s stock, valued at approximately $27,263,672.90. The disclosure for this sale can be found here. Over the last three months, insiders sold 73,469 shares of company stock worth $3,067,434. 1.10% of the stock is owned by corporate insiders.
Equitable Price Performance
Shares of EQH opened at $41.71 on Wednesday. Equitable Holdings, Inc. has a 1 year low of $24.65 and a 1 year high of $44.50. The company has a debt-to-equity ratio of 3.06, a current ratio of 0.12 and a quick ratio of 0.12. The company has a market capitalization of $13.57 billion, a price-to-earnings ratio of 12.91 and a beta of 1.42. The business has a 50-day moving average of $40.86 and a 200-day moving average of $39.89.
Equitable (NYSE:EQH – Get Free Report) last issued its quarterly earnings data on Tuesday, July 30th. The company reported $1.43 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.40 by $0.03. Equitable had a return on equity of 87.49% and a net margin of 7.87%. The company had revenue of $3.51 billion during the quarter, compared to the consensus estimate of $3.71 billion. During the same period last year, the company earned $1.17 earnings per share. The firm’s revenue was up 47.7% compared to the same quarter last year. As a group, equities research analysts anticipate that Equitable Holdings, Inc. will post 6.01 earnings per share for the current year.
Equitable Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, August 13th. Stockholders of record on Tuesday, August 6th were given a dividend of $0.24 per share. The ex-dividend date was Tuesday, August 6th. This represents a $0.96 dividend on an annualized basis and a dividend yield of 2.30%. Equitable’s dividend payout ratio (DPR) is 29.72%.
Equitable Company Profile
Equitable Holdings, Inc, together with its consolidated subsidiaries, operates as a diversified financial services company worldwide. The company operates through six segments: Individual Retirement, Group Retirement, Investment Management and Research, Protection Solutions, Wealth Management, and Legacy.
Recommended Stories
- Five stocks we like better than Equitable
- Insider Trading – What You Need to Know
- Why Lennar Stock Could Be the Best Play in the Housing Market
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- 2 Energy Stocks Fueling the AI Datacenter Boom
- What Do S&P 500 Stocks Tell Investors About the Market?
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Equitable Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Equitable and related companies with MarketBeat.com's FREE daily email newsletter.